{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:08:51Z","timestamp":1793945331572,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","award":["INV-019496"],"award-info":[{"award-number":["INV-019496"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214321\/Z\/18\/Z"],"award-info":[{"award-number":["214321\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203135\/Z\/16\/Z"],"award-info":[{"award-number":["203135\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"National Institutes of Health Fogarty International Center","doi-asserted-by":"publisher","award":["D43 TW010559"],"award-info":[{"award-number":["D43 TW010559"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijid.2025.107876","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T18:02:52Z","timestamp":1741456972000},"page":"107876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"special_numbering":"C","title":["Tuberculosis and HIV coinfection: Progress and challenges towards reducing incidence and mortality"],"prefix":"10.1016","volume":"155","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-3351","authenticated-orcid":false,"given":"Bianca","family":"Sossen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mmamapudi","family":"Kubjane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.107876_bib0001","unstructured":"World Health Organization. Global tuberculosis report 2024. Geneva; World Health Organization, 2024."},{"key":"10.1016\/j.ijid.2025.107876_bib0002","unstructured":"UNAIDS. Data 2024, https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/data-book-2024_en.pdf; 2024 [accessed 10 January 2025]."},{"key":"10.1016\/j.ijid.2025.107876_bib0003","doi-asserted-by":"crossref","unstructured":"Lawn SD, Myer L, Edwards D, Bekker L-G, Wood R. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS 2009;23:1717\u201325. 10.1097\/QAD.0b013e32832d3b6d.","DOI":"10.1097\/QAD.0b013e32832d3b6d"},{"key":"10.1016\/j.ijid.2025.107876_bib0004","doi-asserted-by":"crossref","unstructured":"Ellis PK, Martin WJ, Dodd PJ. CD4 count and tuberculosis risk in HIV-positive adults not on ART: a systematic review and meta-analysis. PeerJ 2017;5:e4165. 10.7717\/peerj.4165.","DOI":"10.7717\/peerj.4165"},{"key":"10.1016\/j.ijid.2025.107876_bib0005","doi-asserted-by":"crossref","unstructured":"Suthar AB, Lawn SD, Del Amo J, Del Amo J, Getahun H, Dye C, et al. Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med 2012;9:e1001270. 10.1371\/journal.pmed.1001270.","DOI":"10.1371\/journal.pmed.1001270"},{"key":"10.1016\/j.ijid.2025.107876_bib0006","unstructured":"World Health Organization. WHO THREE I's MEETING: Intensified Case Finding (ICF), Isoniazid Preventive Therapy (IPT) and TB Infection Control (IC) for people living with HIV. Geneva: World Health Organization, 2008."},{"key":"10.1016\/j.ijid.2025.107876_bib0007","doi-asserted-by":"crossref","unstructured":"Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002\u20132013: a meta-analysis. Clin Infect Dis 2015;60:1120\u20137. 10.1093\/cid\/ciu1137.","DOI":"10.1093\/cid\/ciu1137"},{"key":"10.1016\/j.ijid.2025.107876_bib0008","doi-asserted-by":"crossref","unstructured":"Carmona S, Bor J, Nattey C, Maughan-Brown B, Maskew M, Fox MP, et al. Persistent high burden of advanced HIV disease among patients seeking care in South Africa's national HIV program: data from a nationwide laboratory cohort. Clin Infect Dis 2018;66:S111\u20137. 10.1093\/cid\/ciy045.","DOI":"10.1093\/cid\/ciy045"},{"key":"10.1016\/j.ijid.2025.107876_bib0009","doi-asserted-by":"crossref","unstructured":"Sultana ZZ, Hoque FU, Beyene J, Akhlak-Ul-Islam M, Khan MH, Ahmed S, et al. HIV infection and multidrug resistant tuberculosis: a systematic review and meta-analysis. BMC Infect Dis 2021;21:51. 10.1186\/s12879-020-05749-2.","DOI":"10.1186\/s12879-020-05749-2"},{"key":"10.1016\/j.ijid.2025.107876_bib0010","doi-asserted-by":"crossref","unstructured":"Horton KC, MacPherson P, Houben RMGJ, White RG, Corbett EL. Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med 2016;13:e1002119. 10.1371\/journal.pmed.1002119.","DOI":"10.1371\/journal.pmed.1002119"},{"key":"10.1016\/j.ijid.2025.107876_bib0011","unstructured":"GBD 2019 Tuberculosis Collaborators. Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990\u20132019: results from the Global Burden of Disease Study 2019. Lancet Infect Dis 2022;22:222\u201341. 10.1016\/S1473-3099(21)00449-7."},{"key":"10.1016\/j.ijid.2025.107876_bib0012","doi-asserted-by":"crossref","unstructured":"Hermans S, Cornell M, Middelkoop K, Wood R. The differential impact of HIV and antiretroviral therapy on gender-specific tuberculosis rates. Trop Med Int Health 2019;24:454\u201362. 10.1111\/tmi.13209.","DOI":"10.1111\/tmi.13209"},{"key":"10.1016\/j.ijid.2025.107876_bib0013","doi-asserted-by":"crossref","unstructured":"Kubjane M, Cornell M, Osman M, Boulle A, Johnson LF. Drivers of sex differences in the South African adult tuberculosis incidence and mortality trends, 1990\u20132019. Sci Rep 2023;13:9487. 10.1038\/s41598-023-36432-6.","DOI":"10.1038\/s41598-023-36432-6"},{"key":"10.1016\/j.ijid.2025.107876_bib0014","unstructured":"World Health Organization. Policy brief on tuberculosis- associated disability, https:\/\/iris.who.int\/bitstream\/handle\/10665\/373679\/9789240077799-eng.pdf; 2023 [accessed 14 December 2024]."},{"key":"10.1016\/j.ijid.2025.107876_bib0015","doi-asserted-by":"crossref","unstructured":"Menzies NA, Quaife M, Allwood BW, Byrne AL, Coussens AK, Harries AD, et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. Lancet Glob Health 2021;9:e1679\u201387. 10.1016\/S2214-109X(21)00367-3.","DOI":"10.1016\/S2214-109X(21)00367-3"},{"key":"10.1016\/j.ijid.2025.107876_bib0016","unstructured":"Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) Disability Weights. Seattle: Institute for Health Metrics and Evaluation, 2020."},{"key":"10.1016\/j.ijid.2025.107876_bib0017","doi-asserted-by":"crossref","unstructured":"Coussens AK, Zaidi SMA, Allwood BW, Dewan PK, Gray G, Kohli M, et al. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise. Lancet Respir Med 2024;12:484\u201398. 10.1016\/S2213-2600(24)00028-6.","DOI":"10.1016\/S2213-2600(24)00028-6"},{"key":"10.1016\/j.ijid.2025.107876_bib0018","doi-asserted-by":"crossref","unstructured":"Frascella B, Richards A, Sossen B, Emery JC, Odone A, Law I, et al. Subclinical tuberculosis disease - a review and analysis of prevalence surveys to inform definitions, burden, associations and screening methodology. Clin Infect Dis 2021;73:e830\u201341. 10.1093\/cid\/ciaa1402","DOI":"10.1093\/cid\/ciaa1402"},{"key":"10.1016\/j.ijid.2025.107876_bib0019","doi-asserted-by":"crossref","unstructured":"Moyo S, Ismail F, Van Der Walt M, Ismail N, Mkhondo N, Dlamini S, et al. Prevalence of bacteriologically confirmed pulmonary tuberculosis in South Africa, 2017\u201319: a multistage, cluster-based, cross-sectional survey. Lancet Infect Dis 2022;22:1172\u201380. 10.1016\/S1473-3099(22)00149-9.","DOI":"10.1016\/S1473-3099(22)00149-9"},{"key":"10.1016\/j.ijid.2025.107876_bib0020","doi-asserted-by":"crossref","unstructured":"Carter N, Webb EL, Lebina L, Motsomi K, Bosch Z, Martinson NA, et al. Prevalence of subclinical pulmonary tuberculosis and its association with HIV in household contacts of index tuberculosis patients in two South African provinces: a secondary, cross-sectional analysis of a cluster-randomised trial. BMC Glob Public Health 2023;1:21. 10.1186\/s44263-023-00022-5.","DOI":"10.1186\/s44263-023-00022-5"},{"key":"10.1016\/j.ijid.2025.107876_bib0021","doi-asserted-by":"crossref","unstructured":"Teo AKJ, MacLean EL-H, Fox GJ. Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics. Eur Respir Rev 2024;33:230208. 10.1183\/16000617.0208-2023.","DOI":"10.1183\/16000617.0208-2023"},{"key":"10.1016\/j.ijid.2025.107876_bib0022","doi-asserted-by":"crossref","unstructured":"Bajema KL, Bassett IV, Coleman SM, Ross D, Freedberg KA, Wald A, et al. Subclinical tuberculosis among adults with HIV: clinical features and outcomes in a South African cohort. BMC Infect Dis 2019;19:14. 10.1186\/s12879-018-3614-7.","DOI":"10.1186\/s12879-018-3614-7"},{"key":"10.1016\/j.ijid.2025.107876_bib0023","doi-asserted-by":"crossref","unstructured":"Richards AS, Sossen B, Emery JC, Horton KC, Heinsohn T, Frascella B, et al. Quantifying progression and regression across the spectrum of pulmonary tuberculosis: a data synthesis study. Lancet Glob Health 2023;11:e684\u201392. 10.1016\/S2214-109X(23)00082-7.","DOI":"10.1016\/S2214-109X(23)00082-7"},{"key":"10.1016\/j.ijid.2025.107876_bib0024","doi-asserted-by":"crossref","unstructured":"Barr DA, Lewis JM, Feasey N, Schutz C, Kerkhoff AD, Jacob ST, et al. Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data. Lancet Infect Dis 2020;20:742\u201352. 10.1016\/S1473-3099(19)30695-4.","DOI":"10.1016\/S1473-3099(19)30695-4"},{"key":"10.1016\/j.ijid.2025.107876_bib0025","doi-asserted-by":"crossref","unstructured":"Schutz C, Barr D, Andrade BB, Shey M, Ward A, Janssen S, et al. Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: a prospective cohort study. PLoS Med 2019;16:e1002840. 10.1371\/journal.pmed.1002840.","DOI":"10.1371\/journal.pmed.1002840"},{"key":"10.1016\/j.ijid.2025.107876_bib0026","doi-asserted-by":"crossref","unstructured":"Boloko L, Schutz C, Sibiya N, Balfour A, Ward A, Shey M, et al. Xpert Ultra testing of blood in severe HIV-associated tuberculosis to detect and measure Mycobacterium tuberculosis blood stream infection: a diagnostic and disease biomarker cohort study. Lancet Microbe 2022;3:e521\u201332. 10.1016\/S2666-5247(22)00062-3.","DOI":"10.1016\/S2666-5247(22)00062-3"},{"key":"10.1016\/j.ijid.2025.107876_bib0027","doi-asserted-by":"crossref","unstructured":"Donovan J, Bang ND, Imran D, Nghia HD, Burhan E, Huong DT, et al. Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults. N Engl J Med 2023;389:1357\u201367. 10.1056\/NEJMoa2216218.","DOI":"10.1056\/NEJMoa2216218"},{"key":"10.1016\/j.ijid.2025.107876_bib0028","doi-asserted-by":"crossref","unstructured":"Donovan J, Thwaites GE, Huynh J. Tuberculous meningitis: where to from here? Curr Opin Infect Dis 2020;33:259\u201366. 10.1097\/QCO.0000000000000648.","DOI":"10.1097\/QCO.0000000000000648"},{"key":"10.1016\/j.ijid.2025.107876_bib0029","doi-asserted-by":"crossref","unstructured":"Yanes-Lane M, Ortiz-Brizuela E, Campbell JR, Benedetti A, Churchyard G, Oxlade O, et al. Tuberculosis preventive therapy for people living with HIV: a systematic review and network meta-analysis. PLoS Med 2021;18:e1003738. 10.1371\/journal.pmed.1003738.","DOI":"10.1371\/journal.pmed.1003738"},{"key":"10.1016\/j.ijid.2025.107876_bib0030","doi-asserted-by":"crossref","unstructured":"Duong T, Brigden J, Simon Schaaf H, Garden F, Marais BJ, Anh Nguyen T, et al. A meta-analysis of levofloxacin for contacts of multidrug-resistant tuberculosis. NEJM Evid 2025;4:EVIDoa2400190.","DOI":"10.1056\/EVIDoa2400190"},{"key":"10.1016\/j.ijid.2025.107876_bib0031","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment. Geneva: World Health Organization, 2024."},{"key":"10.1016\/j.ijid.2025.107876_bib0032","doi-asserted-by":"crossref","unstructured":"Teixeira LAA, Santos B, Correia MG, Valiquette C, Bastos ML, Menzies D, et al. Long-term protective effect of tuberculosis preventive therapy in a medium\/high tuberculosis incidence setting. Clin Infect Dis 2024;78:1321\u20137. 10.1093\/cid\/ciae101.","DOI":"10.1093\/cid\/ciae101"},{"key":"10.1016\/j.ijid.2025.107876_bib0033","unstructured":"Martinez L, Cords O, Liu Q, Acuna-Villaorduna C, Bonnet M, Fox GJ, et al. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis. Lancet Glob Health 2022;10:e1307\u201316. 10.1016\/S2214-109X(22)00283-2."},{"key":"10.1016\/j.ijid.2025.107876_bib0034","doi-asserted-by":"crossref","unstructured":"Tait DR, Hatherill M, Van Der Meeren O, Ginsberg AM, Van Brakel E, Salaun B, et al. Final analysis of a trial of M72\/AS01E vaccine to prevent tuberculosis. N Engl J Med 2019;381:2429\u201339. 10.1056\/NEJMoa1909953.","DOI":"10.1056\/NEJMoa1909953"},{"key":"10.1016\/j.ijid.2025.107876_bib0035","doi-asserted-by":"crossref","unstructured":"Von Reyn CF, Mtei L, Arbeit RD, Waddell R, Cole B, Mackenzie T, et al. Prevention of tuberculosis in Bacille Calmette\u2013Gu\u00e9rin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine. AIDS 2010;24:675\u201385. 10.1097\/QAD.0b013e3283350f1b.","DOI":"10.1097\/QAD.0b013e3283350f1b"},{"key":"10.1016\/j.ijid.2025.107876_bib0036","doi-asserted-by":"crossref","unstructured":"Bhargava A, Bhargava M, Meher A, Benedetti A, Velayutham B, Teja GS, et al. Nutritional supplementation to prevent tuberculosis incidence in household contacts of patients with pulmonary tuberculosis in India (RATIONS): a field-based, open-label, cluster-randomised, controlled trial. Lancet 2023;402:627\u201340. 10.1016\/S0140-6736(23)01231-X.","DOI":"10.1016\/S0140-6736(23)01231-X"},{"key":"10.1016\/j.ijid.2025.107876_bib0037","doi-asserted-by":"crossref","unstructured":"Bock P, Jennings K, Vermaak R, Cox H, Meintjes G, Fatti G, et al. Incidence of tuberculosis among HIV-positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa. J Acquir Immune Defic Syndr 2018;77:93\u2013101. 10.1097\/QAI.0000000000001560.","DOI":"10.1097\/QAI.0000000000001560"},{"key":"10.1016\/j.ijid.2025.107876_bib0038","unstructured":"World Health Organization. WHO operational handbook on tuberculosis: module 2: screening: systematic screening for tuberculosis disease. Geneva: World Health Organization, 2021."},{"key":"10.1016\/j.ijid.2025.107876_bib0039","unstructured":"Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX, Kredo T, et al. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis 2022;22:507\u201318. 10.1016\/S1473-3099(21)00387-X."},{"key":"10.1016\/j.ijid.2025.107876_bib0040","doi-asserted-by":"crossref","unstructured":"Dhana A, Hamada Y, Kengne AP, Kerkhoff AD, Rangaka MX, Kredo T, et al. Tuberculosis screening among HIV-positive inpatients: a systematic review and individual participant data meta-analysis. Lancet HIV 2022;9:e233\u201341. 10.1016\/S2352-3018(22)00002-9.","DOI":"10.1016\/S2352-3018(22)00002-9"},{"key":"10.1016\/j.ijid.2025.107876_bib0041","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis rapid diagnostics for tuberculosis detection; Module 3: diagnosis. 3rd ed. Geneva: World Health Organization, 2024."},{"key":"10.1016\/j.ijid.2025.107876_bib0042","doi-asserted-by":"crossref","unstructured":"Zifodya JS, Kreniske JS, Schiller I, Kohli M, Dendukuri N, Schumacher SG, et al. Xpert Ultra versus Xpert MTB\/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis. Cochrane Database Syst Rev 2021;2:CD009593. 10.1002\/14651858.CD009593.pub5.","DOI":"10.1002\/14651858.CD009593.pub5"},{"key":"10.1016\/j.ijid.2025.107876_bib0043","doi-asserted-by":"crossref","unstructured":"Penn-Nicholson A, Gomathi SN, Ugarte-Gil C, Meaza A, Lavu E, Patel P, et al. A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays. Eur Respir J 2021;58:2100526. 10.1183\/13993003.00526-2021.","DOI":"10.1183\/13993003.00526-2021"},{"key":"10.1016\/j.ijid.2025.107876_bib0044","doi-asserted-by":"crossref","unstructured":"Bjerrum S, Schiller I, Dendukuri N, Kohli M, Nathavitharana RR, Zwerling AA, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev 2019;10:CD011420. 10.1002\/14651858.CD011420.pub3.","DOI":"10.1002\/14651858.CD011420.pub3"},{"key":"10.1016\/j.ijid.2025.107876_bib0045","doi-asserted-by":"crossref","unstructured":"Peter JG, Zijenah LS, Chanda D, Clowes P, Lesosky M, Gina P, et al. Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial. Lancet 2016;387:1187\u201397. 10.1016\/S0140-6736(15)01092-2.","DOI":"10.1016\/S0140-6736(15)01092-2"},{"key":"10.1016\/j.ijid.2025.107876_bib0046","doi-asserted-by":"crossref","unstructured":"Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, Grint D, Alufandika-Moyo M, et al. Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet 2018;392:292\u2013301. 10.1016\/S0140-6736(18)31267-4.","DOI":"10.1016\/S0140-6736(18)31267-4"},{"key":"10.1016\/j.ijid.2025.107876_bib0047","unstructured":"World Health Organization. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update, 2019, https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329479\/9789241550604-eng.pdf?sequence=1&isAllowed=y&ua=1; 2019 [accessed 25 July 2020]."},{"key":"10.1016\/j.ijid.2025.107876_bib0048","doi-asserted-by":"crossref","unstructured":"Haraka F, Kakolwa M, Schumacher SG, Nathavitharana RR, Denkinger CM, Gagneux S, et al. Impact of the diagnostic test Xpert MTB\/RIF on patient outcomes for tuberculosis. Cochrane Database Syst Rev 2021;5:CD012972. 10.1002\/14651858.CD012972.pub2.","DOI":"10.1002\/14651858.CD012972.pub2"},{"key":"10.1016\/j.ijid.2025.107876_bib0049","doi-asserted-by":"crossref","unstructured":"Broger T, Koeppel L, Huerga H, Miller P, Gupta-Wright A, Blanc FX, et al. Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data. Lancet Glob Health 2023;11:e903\u201316. 10.1016\/S2214-109X(23)00135-3.","DOI":"10.1016\/S2214-109X(23)00135-3"},{"key":"10.1016\/j.ijid.2025.107876_bib0050","doi-asserted-by":"crossref","unstructured":"Cresswell FV, Ellis J, Kagimu E, Bangdiwala AS, Okirwoth M, Mugumya G, et al. Standardized urine-based tuberculosis (TB) screening with TB-lipoarabinomannan and Xpert MTB\/RIF ultra in Ugandan adults with advanced human immunodeficiency virus disease and suspected meningitis. Open Forum Infect Dis 2020;7:ofaa100. 10.1093\/ofid\/ofaa100.","DOI":"10.1093\/ofid\/ofaa100"},{"key":"10.1016\/j.ijid.2025.107876_bib0051","doi-asserted-by":"crossref","unstructured":"\u00c5hsberg J, Puplampu P, Kwashie A, Commey JO, Ganu VJ, Omari MA, et al. Point-of-care urine lipoarabinomannan testing to guide tuberculosis treatment among severely ill inpatients with human immunodeficiency virus in real-world practice: a multicenter stepped wedge cluster-randomized trial from Ghana. Clin Infect Dis 2023;77:1185\u201393. 10.1093\/cid\/ciad316.","DOI":"10.1093\/cid\/ciad316"},{"key":"10.1016\/j.ijid.2025.107876_bib0052","doi-asserted-by":"crossref","unstructured":"Sossen B, Sz\u00e9kely R, Mukoka M, Muyoyeta M, Nakabugo E, Hella J, et al. Urine-Xpert Ultra for the diagnosis of tuberculosis in people living with HIV: a prospective, multicentre, diagnostic accuracy study. Lancet Glob Health 2024;12:e2024\u20132034. 10.1016\/S2214-109X(24)00357-7.","DOI":"10.1016\/S2214-109X(24)00357-7"},{"key":"10.1016\/j.ijid.2025.107876_bib0053","doi-asserted-by":"crossref","unstructured":"Sung J, Nantale M, Nalutaaya A, Bich\u00e9 P, Mukiibi J, Kamoga CE, et al. Evidence for tuberculosis in individuals with Xpert ultra \u201ctrace\u201d sputum during screening of high-burden communities. Clin Infect Dis 2024:78:723\u20139. 10.1093\/cid\/ciad595.","DOI":"10.1093\/cid\/ciad595"},{"key":"10.1016\/j.ijid.2025.107876_bib0054","doi-asserted-by":"crossref","unstructured":"Kay A, Vasiliu A, Carratala-Castro L, Mtafya B, Reyes JE, Maphalala N, et al. Performance of a stool-based quantitative PCR assay for the diagnosis of tuberculosis in adolescents and adults: a multinational, prospective diagnostic accuracy study. Lancet Microbe 2024;5:e433\u201341. 10.1016\/S2666-5247(23)00391-9.","DOI":"10.1016\/S2666-5247(23)00391-9"},{"key":"10.1016\/j.ijid.2025.107876_bib0055","doi-asserted-by":"crossref","unstructured":"Savage HR, Rickman HM, Burke RM, Odland ML, Savio M, Ringwald B, et al. Accuracy of upper respiratory tract samples to diagnose Mycobacterium tuberculosis: a systematic review and meta-analysis. Lancet Microbe 2023;4:e811\u201321. 10.1016\/S2666-5247(23)00190-8.","DOI":"10.1016\/S2666-5247(23)00190-8"},{"key":"10.1016\/j.ijid.2025.107876_bib0056","unstructured":"Centner CM, Munir R, Tagliani E, Rie\u00df F, Brown P, Hayes C, et al. Reflex Xpert MTB\/XDR testing of residual rifampicin-resistant specimens: a clinical laboratory-based diagnostic accuracy and feasibility study in South Africa. Open Forum Infect Dis 2024;11:ofae437. 10.1093\/ofid\/ofae437."},{"key":"10.1016\/j.ijid.2025.107876_bib0057","doi-asserted-by":"crossref","unstructured":"Penn-Nicholson A, Georghiou SB, Ciobanu N, Kazi M, Bhalla M, David A, et al. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB\/XDR assay: a cross-sectional multicentre diagnostic accuracy study. Lancet Infect Dis 2022;22:242\u20139. 10.1016\/S1473-3099(21)00452-7.","DOI":"10.1016\/S1473-3099(21)00452-7"},{"key":"10.1016\/j.ijid.2025.107876_bib0058","doi-asserted-by":"crossref","unstructured":"Auma E, Alberts R, Derendinger B, Venter R, Streicher EM, Pillay S, et al. Diagnostic accuracy of liquidarray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibility. Clin Infect Dis 2024. 10.1093\/cid\/ciae614","DOI":"10.21203\/rs.3.rs-4841978\/v2"},{"key":"10.1016\/j.ijid.2025.107876_bib0059","doi-asserted-by":"crossref","unstructured":"Sharma K, Sharma M, Shree R, Singla N, Joshi H, Modi T, et al. Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis. Tuberculosis (Edinb) 2024;147:102513. 10.1016\/j.tube.2024.102513.","DOI":"10.1016\/j.tube.2024.102513"},{"key":"10.1016\/j.ijid.2025.107876_bib0060","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis Module 4: treatment: drug-susceptible tuberculosis treatment. Geneva: World Health Organization, 2022."},{"key":"10.1016\/j.ijid.2025.107876_bib0061","unstructured":"World Health Organization. Key updates to the treatment of drug-resistant tuberculosis: rapid communication, https:\/\/iris.who.int\/handle\/10665\/378472; 2024 [accessed 14 December 2024]."},{"key":"10.1016\/j.ijid.2025.107876_bib0062","doi-asserted-by":"crossref","unstructured":"Bastard M, Sanchez-Padilla E, Du Cros P, Khamraev AK, Parpieva N, Tillyashaykov M, et al. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: multicenter cohort study. PLoS One 2018;13:e0193491. 10.1371\/journal.pone.0193491.","DOI":"10.1371\/journal.pone.0193491"},{"key":"10.1016\/j.ijid.2025.107876_bib0063","unstructured":"Goodall RL, Meredith SK, Nunn AJ, Bayissa A, Bhatnagar AK, Bronson G, et al. Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (Stream stage 2): an open-label, multicentre, randomised, non-inferiority trial. Lancet 2022;400:1858\u201368. 10.1016\/S0140-6736(22)02078-5."},{"key":"10.1016\/j.ijid.2025.107876_bib0064","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis Module 6: tuberculosis and comorbidities. Geneva: World Health Organization, 2024."},{"key":"10.1016\/j.ijid.2025.107876_bib0065","doi-asserted-by":"crossref","unstructured":"Thwaites GE, Nguyen DB, Nguyen HD, Quy HT, Oanh DT, Thoa NT, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741\u201351. 10.1056\/NEJMoa040573.","DOI":"10.1056\/NEJMoa040573"},{"key":"10.1016\/j.ijid.2025.107876_bib0066","doi-asserted-by":"crossref","unstructured":"Osman M, Meehan S-A, Von Delft A, Du Preez K, Dunbar R, Marx FM, et al. Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa. PLoS One 2021;16:e0252084. 10.1371\/journal.pone.0252084.","DOI":"10.1371\/journal.pone.0252084"},{"key":"10.1016\/j.ijid.2025.107876_bib0067","doi-asserted-by":"crossref","unstructured":"Namale PE, Boloko L, Vermeulen M, Haigh KA, Bagula F, Maseko A, et al. Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial. Trials 2024;25:311. 10.1186\/s13063-024-08119-4.","DOI":"10.1186\/s13063-024-08119-4"},{"key":"10.1016\/j.ijid.2025.107876_bib0068","doi-asserted-by":"crossref","unstructured":"Said B, Nuwagira E, Liyoyo A, Arinaitwe R, Gitige C, Mushagara R, et al. Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial. BMJ Open 2022;12:e061953. 10.1136\/bmjopen-2022-061953.","DOI":"10.1136\/bmjopen-2022-061953"},{"key":"10.1016\/j.ijid.2025.107876_bib0069","doi-asserted-by":"crossref","unstructured":"Namale PE, Abdullahi LH, Fine S, Kamkuemah M, Wilkinson RJ, Meintjes G. Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis. Future Microbiol 2015;10:1077\u201399. 10.2217\/fmb.15.9.","DOI":"10.2217\/fmb.15.9"},{"key":"10.1016\/j.ijid.2025.107876_bib0070","doi-asserted-by":"crossref","unstructured":"Meintjes G, Stek C, Blumenthal L, Thienemann F, Schutz C, Buyze J, et al. Prednisone for the prevention of paradoxical tuberculosis-associated IRIS. N Engl J Med 2018;379:1915\u201325. 10.1056\/NEJMoa1800762.","DOI":"10.1056\/NEJMoa1800762"},{"key":"10.1016\/j.ijid.2025.107876_bib0071","doi-asserted-by":"crossref","unstructured":"Meintjes G, Wilkinson RJ, Morroni C, Pepper DJ, Rebe K, Rangaka MX, et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosiskassociated immune reconstitution inflammatory syndrome. AIDS 2010;24:2381\u201390. 10.1097\/QAD.0b013e32833dfc68.","DOI":"10.1097\/QAD.0b013e32833dfc68"},{"key":"10.1016\/j.ijid.2025.107876_bib0072","doi-asserted-by":"crossref","unstructured":"Joseph Y, Yao Z, Dua A, Severe P, Collins SE, Bang H, et al. Long-term mortality after tuberculosis treatment among persons living with HIV in Haiti. J Int AIDS Soc 2021;24:e25721. 10.1002\/jia2.25721.","DOI":"10.1002\/jia2.25721"},{"key":"10.1016\/j.ijid.2025.107876_bib0073","doi-asserted-by":"crossref","unstructured":"Allwood BW, Byrne A, Meghji J, Rachow A, Van Der Zalm MM, Schoch OD. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Respiration 2021;100:751\u201363. 10.1159\/000512531.","DOI":"10.1159\/000512531"},{"key":"10.1016\/j.ijid.2025.107876_bib0074","doi-asserted-by":"crossref","unstructured":"Taylor J, Bastos ML, Lachapelle-Chisholm S, Mayo NE, Johnston J, Menzies D. Residual respiratory disability after successful treatment of pulmonary tukberculosis: a systematic review and meta-analysis. EClinicalmedicine 2023;59:101979. 10.1016\/j.eclinm.2023.101979.","DOI":"10.1016\/j.eclinm.2023.101979"},{"key":"10.1016\/j.ijid.2025.107876_bib0075","doi-asserted-by":"crossref","unstructured":"Guler R, Ozturk M, Sabeel S, Motaung B, Parihar SP, Thienemann F, et al. Targeting molecular inflammatoryk pathways in granuloma as host-directed therapies for tuberculosis. Front Immunol 2021;12:733853. 10.3389\/fimmu.2021.733853.","DOI":"10.3389\/fimmu.2021.733853"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:46:13Z","timestamp":1786218373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":75,"alternative-id":["S1201971225000992"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107876","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculosis and HIV coinfection: Progress and challenges towards reducing incidence and mortality","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107876"}}